These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30173545)

  • 1. Validating the Predictive Accuracy of the NAPLS-2 Psychosis Risk Calculator in a Clinical High-Risk Sample From the SHARP (Shanghai At Risk for Psychosis) Program.
    Zhang T; Li H; Tang Y; Niznikiewicz MA; Shenton ME; Keshavan MS; Stone WS; McCarley RW; Seidman LJ; Wang J
    Am J Psychiatry; 2018 Sep; 175(9):906-908. PubMed ID: 30173545
    [No Abstract]   [Full Text] [Related]  

  • 2. Personalized Prediction of Psychosis: External Validation of the NAPLS-2 Psychosis Risk Calculator With the EDIPPP Project.
    Carrión RE; Cornblatt BA; Burton CZ; Tso IF; Auther AM; Adelsheim S; Calkins R; Carter CS; Niendam T; Sale TG; Taylor SF; McFarlane WR
    Am J Psychiatry; 2016 Oct; 173(10):989-996. PubMed ID: 27363511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of psychosis in prodrome: development and validation of a simple, personalized risk calculator.
    Zhang T; Xu L; Tang Y; Li H; Tang X; Cui H; Wei Y; Wang Y; Hu Q; Liu X; Li C; Lu Z; McCarley RW; Seidman LJ; Wang J;
    Psychol Med; 2019 Sep; 49(12):1990-1998. PubMed ID: 30213278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor functional recovery is better predicted than conversion in studies of outcomes of clinical high risk of psychosis: insight from SHARP.
    Zhang T; Yang S; Xu L; Tang X; Wei Y; Cui H; Li H; Tang Y; Hui L; Li C; Chen X; Wang J
    Psychol Med; 2020 Jul; 50(9):1578-1584. PubMed ID: 31451124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calculating individualized risk components using a mobile app-based risk calculator for clinical high risk of psychosis: findings from ShangHai At Risk for Psychosis (SHARP) program.
    Zhang T; Xu L; Li H; Woodberry KA; Kline ER; Jiang J; Cui H; Tang Y; Tang X; Wei Y; Hui L; Lu Z; Cao L; Li C; Niznikiewicz MA; Shenton ME; Keshavan MS; Stone WS; Wang J
    Psychol Med; 2021 Mar; 51(4):653-660. PubMed ID: 31839016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External validation and extension of the NAPLS-2 and SIPS-RC personalized risk calculators in an independent clinical high-risk sample.
    Osborne KJ; Mittal VA
    Psychiatry Res; 2019 Sep; 279():9-14. PubMed ID: 31279247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric Properties of Prodromal Questionnaire-Brief Version among Chinese Help-Seeking Individuals.
    Xu L; Zhang T; Zheng L; Li H; Tang Y; Luo X; Sheng J; Wang J
    PLoS One; 2016; 11(2):e0148935. PubMed ID: 26859774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adding a neuroanatomical biomarker to an individualized risk calculator for psychosis: A proof-of-concept study.
    Chung Y; Addington J; Bearden CE; Cadenhead K; Cornblatt B; Mathalon DH; McGlashan T; Perkins D; Seidman LJ; Tsuang M; Walker E; Woods SW; McEwen S; van Erp TGM; Cannon TD;
    Schizophr Res; 2019 Jun; 208():41-43. PubMed ID: 30745066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Individualized Risk Calculator for Research in Prodromal Psychosis.
    Cannon TD; Yu C; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Heinssen R; Jeffries CD; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Kattan MW
    Am J Psychiatry; 2016 Oct; 173(10):980-988. PubMed ID: 27363508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive validity of clinical variables in the "at risk" for psychosis population: international comparison with results from the North American Prodrome Longitudinal Study.
    Thompson A; Nelson B; Yung A
    Schizophr Res; 2011 Mar; 126(1-3):51-7. PubMed ID: 21035313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms.
    Addington J; Liu L; Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; McGlashan TH
    J Nerv Ment Dis; 2015 May; 203(5):328-35. PubMed ID: 25919383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosis-like experiences and distress among adolescents using mental health services.
    Kline E; Thompson E; Bussell K; Pitts SC; Reeves G; Schiffman J
    Schizophr Res; 2014 Feb; 152(2-3):498-502. PubMed ID: 24411529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features.
    Yung AR; Phillips LJ; Yuen HP; McGorry PD
    Schizophr Res; 2004 Apr; 67(2-3):131-42. PubMed ID: 14984872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis.
    Lo Cascio N; Saba R; Hauser M; Vernal DL; Al-Jadiri A; Borenstein Y; Sheridan EM; Kishimoto T; Armando M; Vicari S; Fiori Nastro P; Girardi P; Gebhardt E; Kane JM; Auther A; Carrión RE; Cornblatt BA; Schimmelmann BG; Schultze-Lutter F; Correll CU
    Eur Child Adolesc Psychiatry; 2016 Oct; 25(10):1091-102. PubMed ID: 26921232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical subtypes that predict conversion to psychosis: A canonical correlation analysis study from the ShangHai At Risk for Psychosis program.
    Zhang T; Tang X; Li H; Woodberry KA; Kline ER; Xu L; Cui H; Tang Y; Wei Y; Li C; Hui L; Niznikiewicz MA; Shenton ME; Keshavan MS; Stone WS; Wang J
    Aust N Z J Psychiatry; 2020 May; 54(5):482-495. PubMed ID: 31486343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The early recognition inventory ERIraos assesses the entire spectrum of symptoms through the course of an at-risk mental state.
    Maurer K; Zink M; Rausch F; Häfner H
    Early Interv Psychiatry; 2018 Apr; 12(2):217-228. PubMed ID: 26801553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normative adolescent experiences may confound assessment of positive symptoms in youth at ultra-high risk for psychosis.
    Carol EE; Mittal VA
    Schizophr Res; 2015 Aug; 166(1-3):358-9. PubMed ID: 25986415
    [No Abstract]   [Full Text] [Related]  

  • 18. [Movement disorders as a prodromal sign in individuals at high risk of psychosis].
    van Harten PN; Bakker PR; van Os J
    Tijdschr Psychiatr; 2015; 57(2):77-82. PubMed ID: 25669942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative and qualitative symptomatic differences in individuals at Ultra-High Risk for psychosis and healthy controls.
    Velthorst E; Derks EM; Schothorst P; Becker H; Durston S; Ziermans T; Nieman DH; de Haan L
    Psychiatry Res; 2013 Dec; 210(2):432-7. PubMed ID: 23938166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain Biomarkers of Vulnerability and Progression to Psychosis.
    Cannon TD
    Schizophr Bull; 2016 Jul; 42 Suppl 1(Suppl 1):S127-32. PubMed ID: 26656880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.